4-(3,5-dichlorobenzoyl)-1-oxa-4-azaspiro[4.5]decane-3-carboxylic acid, 95.0%, 1g

(2S,4S)-4-(Diphenylphosphino)-2-[(diphenylphosphino)methyl]-N-phenyl-1-pyrrolidinecarboxamide, 98%, 5g

4-Fluoro-1H-indazole-5-carbonitrile, 95.0%, 1g

Gal[2346Ac]beta(1-3)GlcNPhth[46Bzd]-beta-MP>98.0%(HPLC)(qNMR)1g

1,1'-Dimethyl-1H,1'H-2,2'-biimidazole, 98%, 1g

(S)-2-((tert-Butoxycarbonyl)amino)-3-(4-cyanophenyl)propanoic acid, 95.0%, 10g

5-Bromo-3-fluoropicolinonitrile, 95.0%, 25g

Acenaphthenequinone>98.0%(GC)25g

3-(3-pyridinyl)-1-propanamine, 95.0%, 5g

8-Bromo-2,3,4,5-tetrahydro-1H-1-benzazepin-2-one, 95+%, 1g

m-Xileno, mínimo 98,5 %, para síntesis, 2,5 l, envase de vidrio

D(+)-biotina, mínimo 98,5 %, Ph.Eur., para bioquímica, 1 g, envase de vidrio

1-Benzyl-azetidine-2-carboxylic acid benzyl ester, 95.0%, 500mg